AzTrials
AzTrials

Fear of ChildbirthMOTIVENCT05766202

The MOTIVE (Multiparas Overcoming Childbirth Fear Through Intervention and Empowerement) Feasibility Trial

A study testing An group intervention for multiparas with fear of childbirth in people with Fear of Childbirth and Anxiety, run by Tampere University at 1 site in Finland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to develop and pilot an intervention for the treatment of fear of childbirth for multiparas and to evaluate the feasibility of the intervention in the treatment of fear of childbirth in multiparas. Read more about this study

Who is it for?
Ages 18 to 50 years, women only
Conditions the study is for
Fear of Childbirth, Anxiety, Depression
What is being tested?
An group intervention for multiparas with fear of childbirth
Could I receive a placebo?
No, everyone receives an active treatment
How many people
19 participants
Where
1 siteFinland
Study dates
27 Apr 2023to 5 Jun 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • over 18 years of age
  • understands finnish language
  • has self reported fear of childbirth
  • is a multipara
  • under 35 weeks pregnant
  • willingness to participate in the study

Who cannot join

  • openly psychotic
  • at risk of suicide
  • serious substance abuse problems

Trial locations and contacts

1 site in 1 country.

Finland1 site
  • Kanta-Hämeen Keskussairaala

    Hämeenlinna

Other trials in Finland

About this study

Official title: The Development and Feasibility of Fear of Childbirth Intervention Aiming to Reduce Fear in Pregnant Multiparas: a Mixed Methods Study

The purpose of the study is to develop and pilot an intervention for the treatment of fear of childbirth for multiparas and to evaluate the feasibility of the intervention in the treatment of fear of childbirth in multiparas.

Being tested
An group intervention for multiparas with fear of childbirth
Keywords
Multipara, Psychoeducation, Prenatal class, Midwife, Psychiatric nurse
Medical subject headings
Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • An group intervention for multiparas with fear of childbirthOther

    The intervention consists of 4 group meetings, three during pregnancy and once after giving birth. It also includes a phone call.

Study groups in NCT05766202
Study groupRoleWhat they receive
Pilot intervention for multiparas with fear of childbirthOtherA group intervention with four meetings and one telephone call.
Receives: Other: An group intervention for multiparas with fear of childbirth

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of Fear of Childbirth from baseline to pregnancy week 36 to 8 weeks after birth

    The FOBS (Fear of Birth scale) is a validated, self-reported instrument assessing fear of childbirth. Possible scores range from 0 (no fear) to 100 (worst possible fear). Change= (week 36 score - baseline score and 8 weeks after birth - baseline).

    Measured: Baseline, week 36 of pregnancy and 8 weeks after birth

Secondary outcomes (5)
  1. Depression

    EPDS (Edinburgh postnatal depression scale) is a validated, self-reported instrument assessing depression.Change= (week 36 score - baseline score and 8 weeks after birth - baseline). Possible scores range from 0 to 30 points. A higher score pointing towards a worse outcome.

    Measured: Baseline, week 36 of pregnancy and 8 weeks after birth

  2. Anxiety

    HADS-A (Hospital Anxiety and depression scale - anxiety) is a validated, self-reported instrument assessing anxiety. Change= (week 36 score - baseline score and 8 weeks after birth - baseline).Possible scores range from 0 to 21 points. A higher score pointing towards a worse outcome.

    Measured: Baseline, week 36 of pregnancy and 8 weeks after birth

  3. Childbirth experience

    CPS (Childbirth perception scale) is a validated, self-reported instrument assessing childbirth experience. Possible scores range from 0 to 48 points. A higher score pointing towards a worse outcome.

    Measured: Only one measurement point, at 8-weeks after birth.

  4. Pregnancy related anxiety

    PRAQ-R2 (Pregnancy Related Anxiety Questionnaire for multiparas) is a validated, self-reported instrument assessing pregnancy related anxiety. Possible scores range from 10 to 50 points. A lower score pointing towards a worse outcome.

    Measured: Baseline and week 36 of pregnancy

  5. Maternal childbirth experience

    VAS (the visual analogue scale) is a ten-point horizontal line with verbal anchors at the extremes of the scale, where higher scores mean better outcomes. The minimum value is 1, and maximum value is 10. VAS has been used to measure the childbirth experience or satisfaction with the childbirth experience in various studies. In addition, VAS has been successfully tested against more detailed measurement instruments, such as the childbirth experience questionnaire (CEQ) and the Wijma Delivery Expectations / Experience Questionnaire (WDEQ-B).

    Measured: Only one measurement point, at 8-weeks after birth.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2023
  2. Study start27 Apr 2023
  3. Primary completion29 May 2024
  4. Study completion5 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
19 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05766202
Sponsor's protocol ID
ETL-R22124H
Acronym
MOTIVE
Status last verified
Jun 2024
First submitted
1 Mar 2023
Last updated
11 Jun 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sandstrom L, Kaunonen M, Huhtala H, Aho AL. Evaluating a Group-Based Intervention Addressing Fear of Childbirth in Multiparous Pregnant Women: A Mixed Methods Feasibility Study. J Adv Nurs. 2026 Apr;82(4):3872-3890. doi: 10.1111/jan.17073. Epub 2025 May 23.

    PubMed 40405826

Questions about this trial

What is this clinical trial studying?

A study testing An group intervention for multiparas with fear of childbirth in people with Fear of Childbirth and Anxiety, run by Tampere University at 1 site in Finland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Finland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of Fear of Childbirth from baseline to pregnancy week 36 to 8 weeks after birth (time frame: Baseline, week 36 of pregnancy and 8 weeks after birth). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05766202, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in